Menstrual Health

More Than 16% of Women Experience Abnormal Uterine Bleeding According to New Findings of Apple’s Women’s Health Study

Apple’s Women’s Health Study set out to identify abnormal uterine bleeding (AUB) patterns and their prevalence in participants and to confirm existing and expected associations between AUB patterns, demographics, and medical conditions. The results are in, have been published in AJOG, and suggest that 16.4% of women in the study experience AUB. 2.9% had irregular menses, 8.4% had infrequent menses, 2.3% had…

UK-based Emm Raises $1M in Pre-seed funding to Take its Smart Menstrual Cup to Market

UK-based biotech startup Emm, has developed a novel smart menstrual cup that uses proprietary sensing technology to monitor and analyze specific biometrics to empower and inform the user through unique health insights and data regarding their menstrual cycle. Having closed its pre-seed funding of over $1M, it is now in beta-testing, readying for full production and launch in 2023. Emm was founded…

TCM Platform Elix’s Hero Product ‘Cycle Balance’ Shows Promise in Clinical Trial

Elix, the first digital platform to combine Traditional Chinese Medicine (TCM) with a proprietary algorithm to empower self-healinghas announced the results of a clinical trial that validates the efficacy of its signature product, Cycle Balance, a personalized formula of medicinal herbs. Cycle Balance holistically supports menstrual symptoms by treating underlying hormonal imbalances, on significantly reducing the severity of 15 common menstrual symptoms…

Endometriosis DTx Endo-App Is Now Reimbursed as a Prescription Digital Health Product (DiGA) in Germany

Last month the German government added Endo-App, a digital therapeutic for endometriosis sufferers, to its DiGA directory after the app successfully completed the Federal Institute for Drugs and Medical Devices’ (in German: Bundesinstitut für Arzneimittel und Medizinprodukte aka BfArM) assessment procedure. The DiGa database is essentially a collection of regulated digital health products reimbursed via the government’s fast-track program. Per definition DiGAs are CE-marked medical devices…

New Research by DotLab Finds Big Consumer and Provider Interest in Novel, Non-Invasive Endometriosis Tests

DotLab is a company on a mission to solve some of the world’s most significant diagnostic challenges via the latest advancements in multiomics and computational biology. The company delivers clinical innovations to areas of significant unmet need. The company is harnessing its expertise with novel, cutting-edge biomarkers and the power of machine learning to deliver non-invasive tests, starting with endometriosis. This past…

Ecosystem: New Leadership for Menstrual Health Hub

7 years ago Mariana de la Roche, Danielle Keiser and Milena Bacalja Perianes founded the Menstrual Health Hub (MH Hub) to move menstruation from margins to mainstream by connecting the global menstrual movement that works across sectors. The founding leadership team is now stepping down and handing over the torch to the team at Uninhibited India, who will continue to evolve the…

Xosomix Receives a NIH Phase I Grant to Develop a Diagnostic Biomarker for Endometriosis

Xosomix, a pre-clinical drug discovery company focused on harnessing diagnostic and therapeutic use of exosomes, the critical communication and transport mediators of the body, announced today the awarding of phase I SBIR grant from Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). This grant will enable Xosomix to develop an early diagnostic biomarker for endometriosis. Approximately 10% of…

How Much Do Dads with Teenage Daughters Know about the Menstrual Cycle? INTIMINA Found Out.

After receiving numerous questions from single dads about how to talk to their daughters about menstruation, INTIMINA, a brand dedicated to caring for women’s intimate health and breaking taboos, conducted a survey of 1.258 dads in the US, UK, France, Italy and Spain with daughters between the ages of 10 and 15 last July. The goal of the survey was to determine how…